ETFs Tumble Into Close Amid Revised Vaccine Considerations And Poor Economic Outlook

After attempting to tread water throughout the day, and hold gains made on Monday, stocks plummeted into the close, after reports circulated that drugmaker Moderna Inc.’s vaccine study, which was considered a key factor in Monday’s rally, didn’t generate enough critical data to determine its...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.